Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2016) 41 OC8.5 | DOI: 10.1530/endoabs.41.OC8.5

ECE2016 Oral Communications Thyroid - Translational (5 abstracts)

In vivo effects of repeated thyronamine (T0AM) administration in mice

Carolin Höfig 1 , Lisbeth Harder 2 , Assel Sarsenbayeva 1 , Lutz Schomburg 1 & Jens Mittag 2


1Charité-Universitätsmedizin Berlin, Institut für Experimentelle Endokrinologie, Berlin, Germany; 2Universität zu Lübeck, Center of Brain Behavior and Metabolism CBBM/Medizinische Klinik I, Lübeck, Germany.


Introduction: So far, only two representatives of thyronamines, namely 3-iodothyronamine (3-T1AM) and the iodine–free thyronamine (T0AM), have been detected in vivo. While intensive research is done on the (patho-) physiological function of 3-T1AM, the physiological role of T0AM is poorly studied. Conflicting data have been reported for the acute cardiac effects of T0AM. This project therefore determined whether a repeated administration of T0AM affects cardiovascular function, metabolism or thermoregulation.

Methods: C57BL/6J male mice were injected with a pharmacological dose of T0AM (5 mg/kg/day, 7 days, i.p.). The mice were killed 24 h after the last injection, and organs were collected for subsequent gene expression analysis.

Results: Daily administration of T0AM did not alter body weight, food or water intake, heart rate, blood pressure, brown adipose tissue thermogenesis or body temperature compared to sham-injected controls. There was no significant difference in hepatic glycogen content or mRNA expression of genes involved in cardiac, blood pressure or metabolic control between the treatment groups. While the thyroid hormone (TH) responsive genes Spot14 and selenoprotein S were significantly up-regulated in liver after T0AM treatment, hepatic deiodinase 1 (Dio1) was unaffected, which is in line with unaltered levels of serum total T4 and T3 concentrations. No significant effects were observed on hepatic or renal trace element concentrations like Se, Cu, and Zn.

Conclusions: Our data demonstrate that T0AM displays only minor cardiovascular, metabolic and thermoregulatory activity in mice upon repeated administration. T0AM does not interfere with TH metabolism, and does not affect Dio1 as a most sensitive hepatic TH-target genes or TH serum levels. Hence, T0AM may not constitute a physiologically active TH metabolite.

Article tools

My recent searches

No recent searches.